Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/25/07 → 6/30/14 |
Funding
- Genentech Inc: $72,304.00
A Phase III, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gencitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Promary Peritoneal, or Fallopian Tube Carcinoma
- Ueland, Frederick (PI)
- Depriest, Paul (CoI)
- Desimone, Christopher (CoI)
- Miller, Rachel (CoI)
- Saunders, Brook (CoI)
- VanNagell, John (CoI)